
基本信息:
- 专利标题: POLYPEPTIDES
- 申请号:EP19186391.9 申请日:2011-02-15
- 公开(公告)号:EP3581649A1 公开(公告)日:2019-12-18
- 发明人: GAUDERNACK, Gustav , RASMUSSEN, Anne-Marie , SUSO, Else Marit Inderberg
- 申请人: Ultimovacs ASA
- 申请人地址: Ullernchausséen 64 0379 Oslo NO
- 专利权人: Ultimovacs ASA
- 当前专利权人: Ultimovacs ASA
- 当前专利权人地址: Ullernchausséen 64 0379 Oslo NO
- 代理机构: Arends, William Gerrit
- 优先权: EP10250265 20100216
- 主分类号: C12N9/12
- IPC分类号: C12N9/12 ; A61K38/47 ; A61K39/00
摘要:
A polypeptide comprising the sequence of SEQ. ID NO. 2, 3, 4, 7 or 8. The polypeptide may have the sequence of an immunogenic fragment thereof comprising at least eight amino acids, wherein the immunogenic fragment is not one of SEQ. ID NOS. 6 or 11 to 16. The polypeptide may have a sequence having at least 80% sequence identity to the aforementioned polypeptide or immunogenic fragment. The polypeptide is less than 100 amino acids in length and does not comprise the sequence of any of SEQ. ID NOS. 10, 46, 56, 57 or 59 to 62 and does not consist of the sequence of SEQ ID NO. 58. The polypeptide is useful in the treatment or prophylaxis of cancer.